TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Net premium income has been realized | 2.47%414.47B | 1.97%274.61B | 2.81%136.85B | 1.99%536.44B | 2.23%404.48B | 2.74%269.31B | 2.12%133.11B | -28.92%525.98B | -31.26%395.66B | -36.11%262.13B |
-Net premium income | 2.47%414.47B | 1.97%274.61B | 2.81%136.85B | 1.99%536.44B | 2.23%404.48B | 2.74%269.31B | 2.12%133.11B | -28.01%525.98B | -30.25%395.66B | -35.97%262.13B |
-Including:Total premium income | 2.47%414.47B | 1.97%274.61B | 2.81%136.85B | 1.99%536.44B | 2.23%404.48B | 2.74%269.31B | 2.12%133.11B | -30.87%525.98B | -33.14%395.66B | -37.96%262.13B |
Investment income | 231.77%125.42B | 65.14%65.84B | 0.49%29.86B | 1,541.97%33.32B | 567.09%37.8B | 232.19%39.87B | 213.64%29.72B | -102.96%-2.31B | -90.00%5.67B | -73.22%12B |
Banking income | -11.55%152.93B | -10.75%103.91B | -9.15%53.3B | -0.54%227.55B | 1.46%172.9B | 3.27%116.43B | 4.19%58.67B | 7.19%228.78B | 7.43%170.42B | 7.59%112.74B |
Special items of income | -4.70%169B | -8.95%109.74B | -7.04%55.88B | 0.78%234.55B | 0.72%177.34B | 1.17%120.53B | 0.60%60.11B | -7.04%232.73B | -6.85%176.07B | -4.62%119.14B |
Total income | 8.74%861.82B | 1.46%554.1B | -2.03%275.89B | 4.74%1.03T | 5.98%792.53B | 7.93%546.13B | 27.86%281.6B | -23.49%985.19B | -24.03%747.82B | -26.43%506.01B |
Insurance business expenses and other expenses | -4.48%-703.22B | -0.17%-450.94B | 1.35%-223.28B | -8.17%-911.75B | -7.66%-673.06B | -8.77%-450.18B | -22.50%-226.34B | -59.20%-842.85B | -59.30%-625.17B | -52.34%-413.9B |
-Administration expense | 2.11%-58.95B | 3.81%-38.6B | 5.30%-18.83B | -5.09%-83.88B | 0.36%-60.22B | 0.78%-40.14B | 1.97%-19.89B | 54.92%-79.82B | 52.26%-60.44B | 51.29%-40.45B |
-Financial expenses - expenses | 20.63%-14.44B | 26.86%-9.07B | 15.88%-4.91B | -7.26%-24.35B | -3.98%-18.19B | -5.62%-12.41B | -1.94%-5.84B | 19.17%-22.7B | 20.53%-17.5B | 22.08%-11.75B |
-Exchange Losses-expenditure | -360.61%-516M | -193.55%-508M | -161.13%-302M | -96.18%120M | -91.55%198M | -52.45%543M | 11.51%494M | 148.15%3.14B | 185.73%2.34B | 113.86%1.14B |
-Special items of operating payout | 3.41%-157.73B | 8.67%-101.18B | 8.75%-48.23B | -9.06%-232.59B | -2.26%-163.29B | -5.95%-110.79B | -6.57%-52.86B | 12.90%-213.26B | 11.46%-159.68B | 18.27%-104.57B |
Total payment、 claims and expenses | -4.48%-703.22B | -0.17%-450.94B | 1.35%-223.28B | -8.17%-911.75B | -7.66%-673.06B | -8.77%-450.18B | -22.50%-226.34B | 26.59%-842.85B | 28.20%-625.17B | 32.03%-413.9B |
Operating profit | 59.47%110.45B | 28.24%76.54B | 6.39%42.26B | -32.06%41.05B | -43.52%69.26B | -35.21%59.69B | 11.95%39.72B | -56.72%60.42B | 7.86%122.65B | 16.86%92.11B |
Special items of profit | -4.11%48.14B | -26.61%26.61B | -33.35%10.36B | -3.48%79.07B | --50.2B | --36.27B | --15.54B | --81.92B | ---- | ---- |
Earning before tax | 32.75%158.59B | 7.51%103.16B | -4.79%52.62B | -15.61%120.12B | -2.59%119.47B | 4.16%95.95B | 55.74%55.26B | 1.97%142.34B | 7.86%122.65B | 16.86%92.11B |
Tax | -63.24%-18.54B | -15.39%-14.45B | 16.82%-7.57B | -44.23%-10.84B | -2.13%-11.36B | -26.30%-12.52B | -194.59%-9.1B | 57.71%-7.52B | 31.17%-11.12B | 8.68%-9.92B |
After-tax profit from continuing operations | 29.55%140.05B | 6.33%88.7B | -2.42%45.05B | -18.95%109.27B | -3.06%108.11B | 1.49%83.43B | 42.51%46.17B | 10.69%134.82B | 14.33%111.53B | 20.95%82.2B |
Earning After tax | 29.55%140.05B | 6.33%88.7B | -2.42%45.05B | -18.95%109.27B | -3.06%108.11B | 1.49%83.43B | 42.51%46.17B | 10.69%134.82B | 14.33%111.53B | 20.95%82.2B |
Minority profit | 1.64%20.87B | 3.68%14.09B | 6.76%8.34B | -0.84%23.61B | 9.56%20.54B | 18.41%13.59B | 17.72%7.81B | 17.96%23.81B | 17.81%18.74B | 15.21%11.47B |
Profits attributable to shareholders | 36.09%119.18B | 6.84%74.62B | -4.28%36.71B | -22.83%85.67B | -5.61%87.58B | -1.25%69.84B | 48.89%38.35B | 9.24%111.01B | 13.65%92.78B | 21.93%70.73B |
Basic earnings per share | 36.23%6.73 | 6.85%4.21 | -4.61%2.07 | -23.90%4.84 | -7.14%4.94 | -2.72%3.94 | 47.62%2.17 | 10.23%6.36 | 14.90%5.32 | 23.10%4.05 |
Diluted earnings per share | 35.67%6.58 | 6.46%4.12 | -4.69%2.03 | -24.40%4.74 | -7.44%4.85 | -3.01%3.87 | 46.90%2.13 | 9.62%6.27 | 14.16%5.24 | 22.39%3.99 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.